
Stenride MP 1mg/500mg/15mg Tablet SR
Marketer
Alvoncare Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Stenride MP 1mg/500mg/15mg Tablet SR
Glycemia-Control Triple Action Tablets (1mg/500mg/15mg SR) combine three active ingredients to manage blood glucose. This medication, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It improves insulin effectiveness, consequently reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Take this medication with food to prevent stomach discomfort. If a dose is missed, take it promptly; however, if your next dose is imminent, omit the missed one and resume your usual schedule. Never double the dose. An overdose can result in dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals increases the risk of hypoglycemia. Regular blood sugar monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to starting treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating women must consult their doctor before use. Kidney function tests will be performed before commencing therapy. Limit alcohol consumption, as it may heighten the risk of adverse reactions.
Primary Ingredients of Stenride MP 1mg/500mg/15mg Tablet SR
No information provided. A rephrased version cannot be created.
Uses of Stenride MP 1mg/500mg/15mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Stenride MP 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Stenride MP 1mg/500mg/15mg sustained-release tablet should be taken with meals.
Common Side effects of Stenride MP 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Stenride MP 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Stenride MP 1mg/500mg/15mg Tablet SR whole; do not chew, crush, or divide the tablet. Administer this medicine with food.
How Stenride MP 1mg/500mg/15mg Tablet SR works:
Stenride MP 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, complements this action by further improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Stenride MP 1mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Stenride MP 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Stenride MP 1mg/500mg/15mg tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Stenride MP 1mg/500mg/15mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Stenride MP 1mg/500mg/15mg Tablet SR. Physician consultation is recommended. Regular assessment of kidney function is advised during treatment.
LiverCAUTION
Patients with hepatic impairment should use Stenride MP 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Stenride MP 1mg/500mg/15mg Tablet SR is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Stenride MP 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Stenride MP 1mg/500mg/15mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Stenride MP 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
